CD5, CD10, and CD23 expression in Waldenström's macroglobulinemia

Clinical Lymphoma

Volumn 5, Issue 4, 2005, Pages 246-249

  Hunter, Zachary R ^a   Branagan, Andrew R ^a   Manning, Robert ^a   Patterson, Christopher J ^a   Santos, Daniel Ditzel ^a,c   Tournilhac, Olivier ^a,c   Dorfman, David M ^b,c   Treon, Steven P ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

B cell disorder; Bone marrow lymphoplasmacytic cells; Hyperviscosity

Indexed keywords

BETA 2 MICROGLOBULIN; CD19 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; FAMILY HISTORY; FLOW CYTOMETRY; HEMATOCRIT; HUMAN; LABORATORY DIAGNOSIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; SPLENOMEGALY; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; TUMOR CELL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 18144425186     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2005.n.008     Document Type: Article

References (9)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
2. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting- Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835-3849.
3. Pangalis GA, Kyrtsonis MC, Kontopidou FN, et al. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lympho-proliferative disorders. Semin Oncol 2003; 30:201-205.
4. Remstein ED, Hanson CA, Kyle RA, et al. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobunlinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol 2003; 30:182-186.
5. San Miguel JF, Vidriales MB, Ocio E, et al. Immunophenotypic analysis of Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:187-195.
6. Owen, RG. Developing diagnostic criteria in Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:196-200.
7. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenström's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. Semin Oncol 2003; 30:110-115.
8. Kilo MN, Dorfman DM. The utility of flow cytometric analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol 1996; 105:451-457.
9. Manning R, Branagan AR, Hunter Z, et al. Characterization of familial Waldenstrom's macroglobulinemia. J Clin Oncol 2003; 22(suppl):572s.